| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/06/2013 | CN102908373A Extraction method of total eoumarins in Chinese medicament common cnidium fruit |
| 02/06/2013 | CN102908369A Process for preparing shiitake extract |
| 02/06/2013 | CN102908367A Preparation method of anticancer medicine |
| 02/06/2013 | CN102908361A Compositions for treatment of mammalian diseases and methods of use |
| 02/06/2013 | CN102908346A Use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas |
| 02/06/2013 | CN102908341A Vitexicarpin used as pharmaceutical active ingredient with anti-angiogenesis function |
| 02/06/2013 | CN102908340A Isolicoflavonol-containing antitumor drug and application thereof |
| 02/06/2013 | CN102908338A Preparation method of resveratrol microcapsule |
| 02/06/2013 | CN102908321A Albumin conjugated taxol nanoparticle freeze-dried preparation and preparation method thereof |
| 02/06/2013 | CN102908318A 10-hydroxycamptothecine nanometer microsphere and preparation method thereof |
| 02/06/2013 | CN102908315A Chitosan (CS) nanoparticle delivery system of small molecular interfering ribonucleic acid and preparation method thereof |
| 02/06/2013 | CN102908309A Direct dissolution of docetaxel in a solvent in polysorbate 80 |
| 02/06/2013 | CN102603627B Naphthlamide derivative used as protein kinase inhibitor and histone deacetylase inhibitor and preparation method of naphthlamide derivative |
| 02/06/2013 | CN102382111B Sulfo-tetrahydro-pyridino-dihydro-pyrimidone derivative, preparation method for same and application thereof |
| 02/06/2013 | CN102335280B Chinese medicinal buccal tablets for benign thyroid tumour postoperation consolidation therapy |
| 02/06/2013 | CN102311475B New compound separated from Ganoderma lucidum, preparation method thereof and medicinal purpose thereof |
| 02/06/2013 | CN102268456B Her-2/neu recombinant adeno-associated virus vector and construction method as well as application thereof |
| 02/06/2013 | CN102146074B Preparation method of pyrrole derivative and application thereof |
| 02/06/2013 | CN101991637B Medicament for inducing apoptosis and application thereof |
| 02/06/2013 | CN101966335B Novel HER2/neu gene-modified dendritic cell vaccine |
| 02/06/2013 | CN101926786B Sustained release preparation for cantharidin and cantharidin extract |
| 02/06/2013 | CN101879427B Doxorubicin hydrochloride-carrying natural polymer-poly(3-benzene acid acrylamide) composite nanospheres, manufacturing method and application thereof |
| 02/06/2013 | CN101861321B Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors |
| 02/06/2013 | CN101827856B 2 ' -fluoro-2 ' -deoxytetrahydrouridines as cytidine deaminase inhibitors |
| 02/06/2013 | CN101665518B Phosphoryl carboxylic acid salinomycin ester derivative and preparing method thereof |
| 02/06/2013 | CN101584854B Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same |
| 02/06/2013 | CN101583366B Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 02/06/2013 | CN101553728B The use of granulin-epithelin precursor (GEP) antibodies for detection and suppression of hepatocellular carcinoma (HCC) |
| 02/06/2013 | CN101528743B Fused heterocyclic derivatives and methods of use |
| 02/06/2013 | CN101389632B Spiroketals |
| 02/06/2013 | CN101365338B Herbal powder extracts and methods of preparing and using the same |
| 02/06/2013 | CN101362717B 4-(4-amidoanilino)-2-(methylcarbamoyl) pyridine, derivates thereof and preparation, application thereof |
| 02/06/2013 | CN101235071B Diene oleanolic acid pentacyclic triterpenes derivatives and use thereof |
| 02/05/2013 | US8367670 Modulators of toll-like receptors |
| 02/05/2013 | US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
| 02/05/2013 | US8367644 Methods and compounds useful to induce apoptosis in cancer cells |
| 02/05/2013 | US8367066 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 02/05/2013 | CA2676188C Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of the b-chronic lymphocytic leukemia |
| 02/05/2013 | CA2589127C 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 02/05/2013 | CA2539767C 1,3-benzoxazolyl derivatives as kinase inhibitors |
| 02/05/2013 | CA2492273C 3, 10, and 12a substituted tetracycline compounds |
| 02/05/2013 | CA2474142C Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 02/05/2013 | CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 02/05/2013 | CA2420867C Methods for enhancing the efficacy of cancer therapy |
| 02/05/2013 | CA2340091C Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 01/31/2013 | WO2013016714A1 Sur-binding proteins against erbb3 |
| 01/31/2013 | WO2013016693A2 Near-infrared light-activated proteins |
| 01/31/2013 | WO2013016675A1 Dendritic cell (dc)-vaccine therapy for pancreatic cancer |
| 01/31/2013 | WO2013016531A2 Compounds and methods for use in treating neoplasia and cancer |
| 01/31/2013 | WO2013016465A1 Target of the phosphoinositide 3-kinase pathway |
| 01/31/2013 | WO2013016452A2 Cancer treatment using bmp inhibitor |
| 01/31/2013 | WO2013016178A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | WO2013016126A1 Therapeutic nanoparticles and methods of use thereof |
| 01/31/2013 | WO2013016081A1 Notch pathway signaling inhibitor compound |
| 01/31/2013 | WO2013015744A1 Mixed lineage leukemia 5 isoform is a potential biomarker and therapeutic target for hpv-associated cervical cancer |
| 01/31/2013 | WO2013015661A2 Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl1-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide |
| 01/31/2013 | WO2013015657A2 Novel compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same |
| 01/31/2013 | WO2013015519A1 Antioxidant composition containing isorhamnetin-3-glucoside-7-rhamnoside separated from hippophae rhamnoides leaves as an active ingredient |
| 01/31/2013 | WO2013015152A1 TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION |
| 01/31/2013 | WO2013014997A1 Auto-magnetic metal salen complex compound |
| 01/31/2013 | WO2013014629A1 Pharmaceutical compositions comprising pyrrole diones and their use to inhibit angiogenesis |
| 01/31/2013 | WO2013014448A1 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
| 01/31/2013 | WO2013014255A1 Exosome inhibiting agents and uses thereof |
| 01/31/2013 | WO2013014170A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit) |
| 01/31/2013 | WO2013014162A1 Heterocyclyl pyrimidine analogues as jak inhibitors |
| 01/31/2013 | WO2013014149A1 Il-12 immunoconjugate |
| 01/31/2013 | WO2013014107A1 Semuloparin for improving the survival of patients with cancer |
| 01/31/2013 | WO2013014039A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors |
| 01/31/2013 | WO2013014038A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors |
| 01/31/2013 | WO2013013640A1 Quinazoline derivative, preparation method therefor, intermediate, composition and application thereof |
| 01/31/2013 | WO2013013639A1 Tnf-related apoptosis-inducing ligand fusion protein and preparation and use thereof |
| 01/31/2013 | WO2013013614A1 4-(3-heteroarylarylamino)quinazoline and 1-(3-heteroarylarylamino)isoquinoline as hedgehog pathway inhibitor and use thereof |
| 01/31/2013 | WO2013013609A1 Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof |
| 01/31/2013 | WO2013013505A1 9-aminomethyl substituted tetracycline compound |
| 01/31/2013 | WO2013013404A1 Water soluble camptothecin derivative, pharmaceutical composition and use thereof |
| 01/31/2013 | WO2013013308A1 Spirocyclic molecules as protein kinase inhibitors |
| 01/31/2013 | WO2013013302A1 Synthetic lethality and the treatment of cancer |
| 01/31/2013 | WO2012170513A3 He4 based therapy for malignant disease |
| 01/31/2013 | WO2012168885A3 Bisacodyl and its analogues as drugs for use in the treatment of cancer |
| 01/31/2013 | WO2012158856A3 Medicaments and methods for treating cancer |
| 01/31/2013 | WO2012143416A3 7 - (3,5 - dimethyl - 4 - isoxazolyl) - 8 - (methyloxy) - 1h - imidazo [4,5 -c] quinoline derivatives |
| 01/31/2013 | WO2012142615A3 Auranofin and auranofin analogs useful to treat proliferative disease and disorders |
| 01/31/2013 | WO2012135630A3 Crk-a novel target for cancer therapy |
| 01/31/2013 | WO2012135562A3 Polymer conjugates targeting cells and methods related thereto |
| 01/31/2013 | WO2012119010A9 Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer |
| 01/31/2013 | WO2012112984A3 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug related applications |
| 01/31/2013 | WO2012094653A4 Compositions and methods for macromolecular drug delivery |
| 01/31/2013 | WO2012030896A9 Methods for treatment of non-small cell lung cancer |
| 01/31/2013 | WO2012022681A3 Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors |
| 01/31/2013 | WO2012006341A8 Anti-ron antibodies |
| 01/31/2013 | US20130031647 Humanized anti cxcr4 antibodies for the treatment of cancer |
| 01/31/2013 | US20130030237 Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors |
| 01/31/2013 | US20130030180 Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators |
| 01/31/2013 | US20130030047 Fatty Acid Derivatives of Catechins and Methods of Their use |
| 01/31/2013 | US20130030044 New series of artemisinin derivatives and process for preparation thereof |
| 01/31/2013 | US20130030041 Near-infrared light-activated proteins |
| 01/31/2013 | US20130030039 Novel multidrug resistance-associated polypeptide |
| 01/31/2013 | US20130030036 Modulation of forkhead box o1a expression |
| 01/31/2013 | US20130030028 Desferrithiocin polyether analogues |
| 01/31/2013 | US20130030027 Hemi-phorboxazole a derivatives and methods of their use |